Search Results 41-50 of 8649 for Raloxifene

  1. Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer - Mayo Clinic

    Tamoxifen or raloxifene therapy should be discontinued before the patient is enrolled on this study. Required Initial Laboratory Data: Granulocytes > 1,500 ...

  2. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

    * Note: Patients who received tamoxifen, raloxifene, aromatase inhibitor or another agent for prevention of breast cancer may be included as long as the ...

  3. Exemestane (oral route) - Side effects & dosage - Mayo Clinic

    It is usually used in women who have already received a cancer medication called tamoxifen. Many breast cancer tumors grow in response to estrogen. Exemestane ...

  4. Leuprolide and norethindrone (intramuscular route, oral route) - Mayo Clinic

    Leuprolide injection and norethindrone tablets are used together to treat pain caused by endometriosis. This combination is also used to prevent the symptoms of ...

  5. Toremifene (oral route) - Side effects & dosage - Mayo Clinic

    Many of the breast cancer tumors will grow when estrogen is available in the body. This medicine blocks the effects of the estrogen hormone. As a result, the ...

  6. A Study to Assess Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer - Mayo Clinic

    Currently receiving tamoxifen or raloxifene. Administration of any investigational agent ≤ 30 days prior to pre-registration. Previous radiation to both ...

  7. Cancer Clinical Trials - Medical Professionals

    The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs ...

  8. A Study Of Low Dose Tamoxifen For Patients At High Risk For Breast Cancer - Mayo Clinic

    Prior use of preventive medications (tamoxifen, raloxifene, exemestane or anastrozole) for breast cancer prevention. Participating Mayo Clinic locations.

  9. A Study To Evaluate The Combination Of Binimetinib And Palbociclib In Treating Patients With KRAS And NRAS Mutant Metastatic Or Unresectable Colorectal Cancer - Mayo Clinic

    The purose of this study is to determine how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive ...

  10. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, and ...